플러스100%마이너스

  • 화면크기
통합검색

한의약융합데이터센터


근거중심한의약 DB

Home > 한의약융합데이터센터 > 근거중심한의약 DB
Title

Acupuncture for Chronic Severe Functional Constipation: A Randomized, Controlled Trial.

Authors

Liu Z, Yan S, Wu J, He L, Li N, Dong G, Fang J, Fu W, Fu L, Sun J, Wang L, Wang S, Yang J, Zhang H, Zhang J, Zhao J, Zhou W, Zhou Z, Ai Y, Zhou K, Liu J, Xu H, Cai Y, Liu B.

Journal

Ann Intern Med.

Year

2016

Vol (Issue)

165(11)

Page

761-9.

doi

10.7326/M15-3118.

PMID

27618593

Url

http://www.ncbi.nlm.nih.gov/pubmed/27618593

MeSH

Keywords

한글 키워드

KMCRIC
Summary & Commentary

KMCRIC 비평 보기 +

Korean Study

Abstract

BACKGROUND:
Acupuncture has been used for chronic constipation, but evidence for its effectiveness remains scarce.
OBJECTIVE:
To determine the efficacy of electroacupuncture (EA) for chronic severe functional constipation (CSFC).
DESIGN:
Randomized, parallel, sham-controlled trial. (ClinicalTrials.gov: NCT01726504).
SETTING:
15 hospitals in China.
PARTICIPANTS:
Patients with CSFC and no serious underlying pathologic cause for constipation.
INTERVENTION:
28 sessions of EA at traditional acupoints or sham EA (SA) at nonacupoints over 8 weeks.
MEASUREMENTS:
The primary outcome was the change from baseline in mean weekly complete spontaneous bowel movements (CSBMs) during weeks 1 to 8. Participants were followed until week 20.
RESULTS:
1075 patients (536 and 539 in the EA and SA groups, respectively) were enrolled. The increase from baseline in mean weekly CSBMs during weeks 1 to 8 was 1.76 (95% CI, 1.61 to 1.89) in the EA group and 0.87 (CI, 0.73 to 0.97) in the SA group (between-group difference, 0.90 [CI, 0.74 to 1.10]; P < 0.001). The change from baseline in mean weekly CSBMs during weeks 9 to 20 was 1.96 (CI, 1.78 to 2.11) in the EA group and 0.89 (CI, 0.69 to 0.95) in the SA group (between-group difference, 1.09 [CI, 0.94 to 1.31]; P < 0.001). The proportion of patients having 3 or more mean weekly CSBMs in the EA group was 31.3% and 37.7% over the treatment and follow-up periods, respectively, compared with 12.1% and 14.1% in the SA group (P < 0.001). Acupuncture-related adverse events during treatment were infrequent in both groups, and all were mild or transient.
LIMITATIONS:
Longer-term follow-up was not assessed. Acupuncturists could not be blinded.
CONCLUSION:
Eight weeks of EA increases CSBMs and is safe for the treatment of CSFC. Additional study is warranted to evaluate a longer-term treatment and follow-up.

국문초록

Language

영어

첨부파일